Broad Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page broadinstitute
Websitehttp://www.broadinstitute.org/
Twitter usernamebroadinstitute
Wikipedia pagehttps://en.wikipedia.org/wiki/Broad_Institute
Instagram usernamebroadinstitute

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 28 764,493 1,717,240 -1,283 85,000 200,000 273,209 637,348 764,493 1,326,484 1,728,130 1,928,229 2,503,845 16,312,343
Global health 28 764,493 1,717,240 -1,283 85,000 200,000 273,209 637,348 764,493 1,326,484 1,728,130 1,928,229 2,503,845 16,312,343

Donation amounts by donor and year for donee Broad Institute

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Bill and Melinda Gates Foundation (filter this donee) 48,082,728.17 500,000.00 1,191,926.11 504,954.00 3,427,475.06 3,456,259.00 19,770,476.00 200,000.00 6,972,563.00 8,123,914.00 3,935,161.00
Total 48,082,728.17 500,000.00 1,191,926.11 504,954.00 3,427,475.06 3,456,259.00 19,770,476.00 200,000.00 6,972,563.00 8,123,914.00 3,935,161.00

Full list of donations in reverse chronological order (28 donations)

DonorAmount (current USD)Amount rank (out of 28)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation500,000.00192018-11-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-1,282.89282017-12-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to obtain, and make immediately available, current and accurate Ebola virus genetic sequence to help ensure that up-to-date information is available to support the global efforts to develop or deploy diagnostics, therapeutics and vaccines for the current ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation273,209.00202017-11-03Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation920,000.00132017-10-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to discover and functionally characterize novel antibiotics using deep learning. Image-based phenoscaping and evaluation of omic cell context networks in bacteria. Investment start date: 10/26/2017 to end date: 12/31/2019. Grantee name: Broad Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation252,477.00212016-11-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation252,477.00212016-11-02Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation637,348.00172015-11-02Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.
Bill and Melinda Gates Foundation612,354.00182015-11-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.
Bill and Melinda Gates Foundation1,326,484.00122015-10-13Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-48.94272015-08-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to better prioritize antimalarial drug candidates by identifying those compounds that inhibit the efficacy of drugs used to treat HIV and tuberculosis (TB) when administered to the same person using an in vitro human microliver model; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation851,338.00142015-01-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to obtain, and make immediately available, current and accurate Ebola virus genetic sequence to help ensure that up-to-date information is available to support the global efforts to develop or deploy diagnostics, therapeutics and vaccines for the current ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,728,129.5092014-10-06Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation1,728,129.5092014-10-06Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation16,312,343.0012013-10-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate novel drug discovery tools to serve as a basis for a comprehensive chemigenomics program; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,774,128.0082013-10-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation764,492.56152013-09-11Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.
Bill and Melinda Gates Foundation734,512.44162013-09-11Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.
Bill and Melinda Gates Foundation85,000.00262013-06-04Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.00242013-04-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to better prioritize antimalarial drug candidates by identifying those compounds that inhibit the efficacy of drugs used to treat HIV and tuberculosis (TB) when administered to the same person using an in vitro human microliver model; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation200,000.00232012-03-21Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,864,873.0072011-10-20Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for P. falciparum genetic diversity: drug, vaccine, and disease severity applications; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.00242011-09-30Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to engineer bacterial viruses to deliver enzymes that can be designed to degrade the genome of pathogenic bacteria.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,503,845.0032011-09-08Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation2,503,845.0032011-09-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify novel/unique small molecules from the Broad Institute’s diversity-oriented synthesis (DOS) library that target the malaria parasite as well as ones that target the causative agent of tuberculosis; Aid type: Project-type interventions. Affected regions: South of Sahara|Developing countries, unspecified.
Bill and Melinda Gates Foundation1,535,508.00112010-10-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to aid drug discovery and vaccine development to accelerate the eradication of malaria; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation6,588,406.0022010-02-05Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for P. falciparum genetic diversity: drug, vaccine, and disease severity applications; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation2,006,932.1252009-11-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.
Bill and Melinda Gates Foundation1,928,228.8862009-11-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify protein biomarkers for future development into rapid diagnostic tests to distinguish bacterial pneumonia, viral pneumonia and malaria in children in rural Africa based on an inexpensive blood test; Aid type: Project-type interventions. Affected regions: Africa|South of Sahara.